Notice: Undefined variable: part in /home/h004323652/b-pharm.ru/docs/index.php on line 189
Notice: Undefined index: part in /home/h004323652/b-pharm.ru/docs/index.php on line 205
Notice: Undefined index: part in /home/h004323652/b-pharm.ru/docs/index.php on line 209
Notice: Undefined index: part in /home/h004323652/b-pharm.ru/docs/index.php on line 213
Notice: Undefined index: part in /home/h004323652/b-pharm.ru/docs/index.php on line 217
Notice: Undefined index: part in /home/h004323652/b-pharm.ru/docs/index.php on line 221
Notice: Undefined index: part in /home/h004323652/b-pharm.ru/docs/index.php on line 225
B-PHARM Pharmaceutical Company - is an innovative, actively and dynamically developing pharmaceutical company.
The core company’s business is:
- Distribution of innovative medicines to medical institutions and pharmacy chains in Russian Federation and other countries.
- Development, registration, production and sale of medicines.

Strategic goals
The company’s main objective is bringing the new innovative medication and medical products to the Russian market by cooperating with the leading pharmaceutical companies, working on patents and certification, and operating in the field of high-quality analytical research.
Within a short period of time, B-PHARM Pharmaceutical Company has proved itself to be a reliable supplier of MIPB consumables and medicines of both domestic and imported origin.
Our principles
Business strategy of the company is based on professionalism of the team, social responsibility, manufacturability and quality control on every stage of the project.
Development priorities:
We develop and expand our partnership with major members of pharmaceutical market as well as the chain of logistics centers allowing us to deliver medication to any part of Russia on schedule.
B-PHARM Pharmaceutical Company is successfully managing the following tasks:
- Expand company’s portfolio with medication of various pharmaceutical areas: oncology, cardiology, immunology, antibacterial, antiviral, diabetes medication.
- Expand research and development part in cooperation with major international companies and pharmaceutical institutions.
- Expand and strengthen distribution network.